ID   cc-006cpm8
AC   CVCL_WP72
DR   cancercelllines; CVCL_WP72
DR   Wikidata; Q93444666
RX   PubMed=31115570;
CC   Population: Chinese.
CC   Doubling time: 27 hours (PubMed=31115570).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=31115570).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
RX   PubMed=31115570; DOI=10.3892/ijo.2019.4806;
RA   Chu X., Xue Y.-Q., Huo X.-Y., Wei J.-S., Chen Y.-T., Han R.-B.,
RA   Chen H., Su X.-Y., Zhang H.-H., Gong Y., Chen J.-F.;
RT   "Establishment and characterization of a novel cell line (cc-006cpm8)
RT   of moderately/poorly differentiated colorectal adenocarcinoma derived
RT   from a primary tumor of a patient.";
RL   Int. J. Oncol. 55:243-256(2019).
//